We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$455B
AUM Growth
+$26.6B
Cap. Flow
-$26.7B
Cap. Flow %
-5.87%
Top 10 Hldgs %
33.25%
Holding
16,292
New
1,466
Increased
6,223
Reduced
6,687
Closed
1,652

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$645M
2
TMUS icon
T-Mobile US
TMUS
+$640M
3
T icon
AT&T
T
+$517M
4
HUM icon
Humana
HUM
+$481M
5
BSX icon
Boston Scientific
BSX
+$400M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.24B
2
AAPL icon
Apple
AAPL
+$755M
3
META icon
Meta Platforms (Facebook)
META
+$707M
4
CAT icon
Caterpillar
CAT
+$472M
5
AMD icon
Advanced Micro Devices
AMD
+$449M

Sector Composition

Rank Sector Weight
1 Healthcare 3.33%
2 Technology 3.2%
3 Financials 2.22%
4 Industrials 2.17%
5 Consumer Discretionary 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHE icon
12276
CALL
Benchmark Electronics
BHE
$2.94B
$42.6K ﹤0.01%
1,800
-2,700
-60% -$68.3K
BIS icon
12277
CALL
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.09M
$42.6K ﹤0.01%
+1,050
New +$41.8K
DOYU
12278
CALL
DouYu International Holdings
DOYU
$142M
$42.6K ﹤0.01%
3,580
-210
-6% -$3.11K
BGSF icon
12279
PUT
BGSF Inc
BGSF
$60.4M
$42.6K ﹤0.01%
4,000
+700
+21% +$9.77K
PST icon
12280
ProShares Trust UltraShort Lehman 7-10 Year Treasury
PST
$10.6M
$42.6K ﹤0.01%
2,033
-11,369
-85% -$245K
HCKT icon
12281
CALL
Hackett Group
HCKT
$265M
$42.5K ﹤0.01%
+2,300
New +$46.4K
UFCS icon
12282
CALL
United Fire Group
UFCS
$1.4B
$42.5K ﹤0.01%
1,600
-1,300
-45% -$37K
TKNO icon
12283
Alpha Teknova
TKNO
$391M
$42.5K ﹤0.01%
+14,348
New +$71.7K
SRRK icon
12284
CALL
Scholar Rock
SRRK
$6.4B
$42.4K ﹤0.01%
5,300
+5,000
+1,667% +$50.7K
GTHX
12285
PUT
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$42.3K ﹤0.01%
15,800
-8,100
-34% -$38.9K
MNOV icon
12286
MediciNova
MNOV
$64.5M
$42.3K ﹤0.01%
19,586
-21,651
-53% -$49.6K
ORIC icon
12287
PUT
Oric Pharmaceuticals
ORIC
$1.44B
$42.2K ﹤0.01%
7,400
+2,600
+54% +$13.6K
STKS icon
12288
CALL
The ONE Group
STKS
$57.8M
$42.1K ﹤0.01%
5,200
+4,600
+767% +$36.2K
TAIT
12289
DELISTED
Taitron Components
TAIT
$42.1K ﹤0.01%
+11,696
New +$43.7K
SCS
12290
PUT
DELISTED
Steelcase
SCS
$42.1K ﹤0.01%
5,000
-100
-2% -$768
EB
12291
PUT
DELISTED
Eventbrite
EB
$42K ﹤0.01%
4,900
+400
+9% +$3.3K
ADV icon
12292
CALL
Advantage Solutions
ADV
$420M
$42K ﹤0.01%
1,064
+928
+682% +$52.4K
OCFT
12293
CALL
DELISTED
OneConnect Financial Technology
OCFT
$42K ﹤0.01%
+7,900
New +$53.2K
RDN icon
12294
PUT
Radian Group
RDN
$4.98B
$42K ﹤0.01%
1,900
-36,600
-95% -$779K
AKBA icon
12295
CALL
Akebia Therapeutics
AKBA
$242M
$41.9K ﹤0.01%
74,800
-14,400
-16% -$11K
SEI
12296
PUT
Solaris Energy Infrastructure
SEI
$4.17B
$41.8K ﹤0.01%
4,900
+4,400
+880% +$42.4K
CUBI icon
12297
Customers Bancorp
CUBI
$2.82B
$41.8K ﹤0.01%
2,255
-168,020
-99% -$4.58M
MMI icon
12298
CALL
Marcus & Millichap
MMI
$1.2B
$41.7K ﹤0.01%
1,300
-2,000
-61% -$69.4K
AVNS
12299
PUT
DELISTED
Avanos Medical
AVNS
$41.6K ﹤0.01%
1,400
+100
+8% +$2.9K
WPRT
12300
PUT
Westport Fuel Systems
WPRT
$33.4M
$41.6K ﹤0.01%
4,370
-650
-13% -$6.66K

Similar funds

Ken Griffin's Q1 2023 Portfolio in Review

As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.

  • Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
  • Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
  • Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
  • Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
  • Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
  • Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
  • Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.